Search Results - "Trino, Stefania"
-
1
Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy
Published in Leukemia (01-03-2021)“…In the era of precision medicine, liquid biopsy is becoming increasingly important in oncology. It consists in the isolation and analysis of tumor-derived…”
Get full text
Journal Article -
2
MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia
Published in International journal of molecular sciences (03-02-2018)“…Acute myeloid leukemias (AML) are clonal disorders of hematopoietic progenitor cells which are characterized by relevant heterogeneity in terms of phenotypic,…”
Get full text
Journal Article -
3
MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation
Published in Oncotarget (09-02-2016)“…Hematopoietic stem cells (HSC), including umbilical cord blood CD34+ stem cells (UCB-CD34+), are used for the treatment of several diseases. Although different…”
Get full text
Journal Article -
4
Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?
Published in International journal of molecular sciences (09-05-2017)“…Mesenchymal stem cells (MSCs) are a heterogeneous cellular population containing different progenitors able to repair tissues, support hematopoiesis, and…”
Get full text
Journal Article -
5
Acute Myeloid Leukemia Cells Functionally Compromise Hematopoietic Stem/Progenitor Cells Inhibiting Normal Hematopoiesis Through the Release of Extracellular Vesicles
Published in Frontiers in oncology (16-03-2022)“…Acute myeloid leukemia (AML) is an aggressive and heterogeneous clonal disorder of hematopoietic stem/progenitor cells (HSPCs). It is not well known how…”
Get full text
Journal Article -
6
DNA methylation of hematopoietic stem/progenitor cells from donor peripheral blood to patient bone marrow: implications for allogeneic hematopoietic stem cell transplantation
Published in Clinical and experimental medicine (01-12-2023)“…Allogeneic hematopoietic stem cell transplantation (AHSCT) is a life-saving treatment for selected hematological malignancies. So far, it remains unclear…”
Get full text
Journal Article -
7
P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia
Published in Frontiers in pharmacology (16-12-2016)“…The tumor suppressor p53 is a canonical regulator of different biological functions, like apoptosis, cell cycle arrest, DNA repair, and genomic stability. This…”
Get full text
Journal Article -
8
Smenamide A Analogues. Synthesis and Biological Activity on Multiple Myeloma Cells
Published in Marine drugs (13-06-2018)“…Smenamides are an intriguing class of peptide/polyketide molecules of marine origin showing antiproliferative activity against lung cancer Calu-1 cells at…”
Get full text
Journal Article -
9
TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumors
Published in Cancer research (Chicago, Ill.) (15-11-2014)“…Human BRAF-driven tumors are aggressive malignancies with poor clinical outcome and lack of sensitivity to therapies. TRAP1 is a HSP90 molecular chaperone…”
Get full text
Journal Article -
10
Advances in Azorella glabra Wedd. Extract Research: In Vitro Antioxidant Activity, Antiproliferative Effects on Acute Myeloid Leukemia Cells and Bioactive Compound Characterization
Published in Molecules (Basel, Switzerland) (22-10-2020)“…Azorella glabra Wedd. (AG) is traditionally used to treat gonorrhea or kidney’s problems. The antioxidant, antidiabetic, anticholinesterase and in vitro…”
Get full text
Journal Article -
11
Future in the Past: Azorella glabra Wedd. as a Source of New Natural Compounds with Antiproliferative and Cytotoxic Activity on Multiple Myeloma Cells
Published in International journal of molecular sciences (26-10-2018)“…Multiple myeloma (MM) is the second most common hematologic malignancy and, although the development of novel agents has improved survival of patients, to…”
Get full text
Journal Article -
12
Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies
Published in Stem cells international (01-01-2018)“…The bone marrow (BM) microenvironment in hematological malignancies (HMs) comprises heterogeneous populations of neoplastic and nonneoplastic cells. Cancer…”
Get full text
Journal Article -
13
Multiple Myeloma-Derived Extracellular Vesicles Impair Normal Hematopoiesis by Acting on Hematopoietic Stem and Progenitor Cells
Published in Frontiers in medicine (16-12-2021)“…Multiple myeloma (MM) is characterized by the abnormal proliferation of clonal plasma cells (PCs) in bone marrow (BM). MM-PCs progressively occupy and likely…”
Get full text
Journal Article -
14
DNA methylation dynamic of bone marrow hematopoietic stem cells after allogeneic transplantation
Published in Stem cell research & therapy (20-05-2019)“…Allogeneic hematopoietic stem cell transplantation (AHSCT) is a curative therapeutic approach for different hematological malignancies (HMs), and epigenetic…”
Get full text
Journal Article -
15
Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine
Published in International journal of molecular sciences (30-07-2015)“…Primary plasma cell leukemia (pPCL) is a rare and aggressive variant of multiple myeloma (MM) which may represent a valid model for high-risk MM. This disease…”
Get full text
Journal Article -
16
A case of acute promyelocytic leukemia variant with derivative chromosome 3 der(3)t(3;8) associated with 8q partial gain
Published in Molecular cytogenetics (05-07-2019)“…Acute promyelocytic leukemia (APL) is characterized by fusion of PML/RARα genes as a result of t(15;17)(q24;q21). APL is now one of the curable hematological…”
Get full text
Journal Article -
17
A Pyrazolo[3,4- d ]pyrimidine Compound Reduces Cell Viability and Induces Apoptosis in Different Hematological Malignancies
Published in Frontiers in pharmacology (07-11-2016)“…Molecular targeted therapies are based upon drugs acting on tumors by interfering with specific targets involved in growth and spread of cancer. Many targeted…”
Get full text
Journal Article -
18
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia
Published in Clinical & developmental immunology (01-01-2013)“…The clinical course of chronic lymphocytic leukemia (CLL) may be complicated at any time by autoimmune phenomena.The most common ones are hematologic…”
Get full text
Journal Article -
19
IL6/STAT3 axis mediates resistance to BRAF inhibitors in thyroid carcinoma cells
Published in Cancer letters (01-10-2018)“…Thyroid carcinomas (TCs) bearing BRAF mutations represent approximately 26–53% of human thyroid malignancies and, differently from melanomas, are poorly…”
Get full text
Journal Article -
20
High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders
Published in Tumor biology (01-12-2015)“…Many cell types release extracellular vesicles (EVs), including exosomes, microvesicles (MVs), and apoptotic bodies, which play a role in physiology and…”
Get full text
Journal Article